Core Laboratories (CLB) Tops Q2 EPS by 28c, provides guidance

Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.48, $0.28 better than the analyst estimate of $0.20. Revenue for the quarter came in at $127.9 million versus the consensus estimate of $132.39 million.

Guidance:
Core projects third quarter 2023 revenue to range from $128,000,000 to $132,000,000 and operating income of $15,200,000 to $17,500,000, yielding operating margins of approximately 13%. EPS for the third quarter of 2023 is expected to be $0.21 to $0.25.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79